Skip to content

H.Res. 1285 · 119th Congress (2025–2027)

Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.

CRS summary not yet available.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.Res. 1285’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Diana DeGette (D-CO-1)
Cosponsors
54 cosponsors

12 original · 42 later

54 D

  1. Rep. Becca Balint (D-VT)· Original · May 14, 2026
  2. Rep. Wesley Bell (D-MO-1)· Original · May 14, 2026
  3. Rep. Katherine M. Clark (D-MA-5)· Original · May 14, 2026
  4. Rep. Maxine Dexter (D-OR-3)· Original · May 14, 2026
  5. Rep. Jesús G. "Chuy" García (D-IL-4)· Original · May 14, 2026
  6. Rep. Seth Moulton (D-MA-6)· Original · May 14, 2026
  7. Rep. Jennifer L. McClellan (D-VA-4)· Original · May 14, 2026
  8. Del. Eleanor Holmes Norton (D-DC)· Original · May 14, 2026
  9. Rep. Ayanna Pressley (D-MA-7)· Original · May 14, 2026
  10. Rep. Brittany Pettersen (D-CO-7)· Original · May 14, 2026
  11. Rep. Paul Tonko (D-NY-20)· Original · May 14, 2026
  12. Rep. Nydia M. Velázquez (D-NY-7)· Original · May 14, 2026
  13. Rep. Kathy Castor (D-FL-14)· Later · May 21, 2026
  14. Rep. André Carson (D-IN-7)· Later · May 21, 2026
  15. Rep. Judy Chu (D-CA-28)· Later · May 21, 2026
  16. Rep. Salud O. Carbajal (D-CA-24)· Later · May 21, 2026
  17. Rep. Jasmine Crockett (D-TX-30)· Later · May 21, 2026
  18. Rep. Christopher R. Deluzio (D-PA-17)· Later · May 21, 2026
  19. Rep. Suzan K. DelBene (D-WA-1)· Later · May 21, 2026
  20. Rep. Sharice Davids (D-KS-3)· Later · May 21, 2026
  21. Rep. Bill Foster (D-IL-11)· Later · May 21, 2026
  22. Rep. Lois Frankel (D-FL-22)· Later · May 21, 2026
  23. Rep. John Garamendi (D-CA-8)· Later · May 21, 2026
  24. Rep. Jared Huffman (D-CA-2)· Later · May 21, 2026
  25. Rep. Jonathan L. Jackson (D-IL-1)· Later · May 21, 2026
  26. Rep. Julie Johnson (D-TX-32)· Later · May 21, 2026
  27. Rep. Timothy M. Kennedy (D-NY-26)· Later · May 21, 2026
  28. Rep. Summer L. Lee (D-PA-12)· Later · May 21, 2026
  29. Rep. Gregory W. Meeks (D-NY-5)· Later · May 21, 2026
  30. Rep. Gwen Moore (D-WI-4)· Later · May 21, 2026
  31. Rep. Dave Min (D-CA-47)· Later · May 21, 2026
  32. Rep. Johnny Olszewski, Jr. (D-MD-2)· Later · May 21, 2026
  33. Rep. Chellie Pingree (D-ME-1)· Later · May 21, 2026
  34. Rep. Deborah K. Ross (D-NC-2)· Later · May 21, 2026
  35. Rep. Janice D. Schakowsky (D-IL-9)· Later · May 21, 2026
  36. Rep. Greg Stanton (D-AZ-4)· Later · May 21, 2026
  37. Rep. Andrea Salinas (D-OR-6)· Later · May 21, 2026
  38. Rep. Lateefah Simon (D-CA-12)· Later · May 21, 2026
  39. Rep. Lori Trahan (D-MA-3)· Later · May 21, 2026
  40. Rep. Ritchie Torres (D-NY-15)· Later · May 21, 2026
  41. Rep. Maxine Waters (D-CA-43)· Later · May 21, 2026
  42. Rep. Frederica S. Wilson (D-FL-24)· Later · May 21, 2026
  43. Rep. Steve Cohen (D-TN-9)· Later · Jun 23, 2026
  44. Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)· Later · Jun 23, 2026
  45. Rep. Mark DeSaulnier (D-CA-10)· Later · Jun 23, 2026
  46. Rep. Josh Gottheimer (D-NJ-5)· Later · Jun 23, 2026
  47. Rep. Joseph D. Morelle (D-NY-25)· Later · Jun 23, 2026
  48. Rep. Sarah McBride (D-DE)· Later · Jun 23, 2026
  49. Rep. Emilia Strong Sykes (D-OH-13)· Later · Jun 23, 2026
  50. Rep. Julia Brownley (D-CA-26)· Later · Jun 24, 2026
  51. Rep. April McClain Delaney (D-MD-6)· Later · Jul 15, 2026
  52. Rep. Nellie Pou (D-NJ-9)· Later · Aug 20, 2026
  53. Rep. Lizzie Fletcher (D-TX-7)· Later · Sep 1, 2026
  54. Rep. Yvette D. Clarke (D-NY-9)· Later · Oct 1, 2026
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Submitted in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the House Committee on Energy and Commerce.

    Sources

Committees

  1. HouseEnergy and CommerceReferred May 14, 2026

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (1)
  1. Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.

    Display title, Official title · Introduced in House